1. C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study 
Heart Protection Study Collaborative Group 
The Lancet 
Volume 377, Issue 9764, Pages (February 2011)
DOI: /S (10)
Copyright © 2011 Elsevier Ltd Terms and Conditions

2. Figure 1
Effect of simvastatin allocation on vascular events by baseline concentration of C-reactive protein
The Lancet  , DOI: ( /S (10) )
Copyright © 2011 Elsevier Ltd Terms and Conditions

3. Figure 2
Effect of simvastatin allocation on vascular and non-vascular death by concentration of baseline C-reactive protein
The Lancet  , DOI: ( /S (10) )
Copyright © 2011 Elsevier Ltd Terms and Conditions

4. Figure 3
Effect of simvastatin allocation on first major vascular event during follow-up by baseline concentrations of LDL cholesterol and CRP
Test for heterogeneity between four groups, excluding participants with missing data for baseline CRP concentration. Threshold values used to define low and high concentrations of LDL cholesterol and CRP are from the median values in the hypothesis-generating trial.8 CRP=C-reactive protein.
The Lancet  , DOI: ( /S (10) )
Copyright © 2011 Elsevier Ltd Terms and Conditions